Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02543723 · ClinicalTrials.gov registry record · NA
Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence
A NA study, sponsored by East Carolina University.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT02543723 is a NA study that has completed, run by East Carolina University. The registered enrollment target is 128 participants.
The verdict
NCT02543723, a NA study, has completed, sponsored by East Carolina University.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
Oral chemotherapeutic agents (OCAs) are increasingly being used as an alternative to traditional intravenous chemotherapy, and factors promoting this trend include increased survival times requiring long-term therapy, acceptability among patients, convenience, and cost savings due to reduced hospital time. Although OCAs are commonly preferred by patients, adherence to these medications vary. Suboptimal medication adherence leads to loss of treatment efficacy, increased toxicity, and increased health care costs. Thus, it is critical to develop and test interventions that effectively improve adherence to OCAs. Although the medication adherence literature has been criticized for methodological issues, some components of interventions have had promising results on adherence such as electronic monitored adherence feedback, cognitive-education, nurse-based interventions, and technology-based or telehealth strategies. The investigators propose to unify components of these effective approaches in a novel way to assess the efficacy and feasibility of two telehealth-based strategies (electronic medication-event monitoring with feedback and tailored nurse coaching which includes cognitive-education) in an effort increase OCA adherence among cancer patients who are at high-risk for non-adherence in rural eastern North Carolina.
Interventions
- BEHAVIORAL Nurse Coach Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2015-11-15 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02543723
The ClinicalTrials.gov registry entry for NCT02543723 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is East Carolina University, which has 58 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nurse Coach Intervention is the first listed.
NCT02543723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02543723 about?
NCT02543723 is a clinical study titled "Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence". Oral chemotherapeutic agents (OCAs) are increasingly being used as an alternative to traditional intravenous chemotherapy, and factors promoting this trend include increased survival times requiring long-term therapy, acceptability among patients, convenience, and cost savings due to reduced hospita...
What is the current status of trial NCT02543723?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2015-11-15. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT02543723?
The interventions under investigation include: Nurse Coach Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02543723?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.